Table 1.
Demographic and pulmonary function parameters of COVID-19 patients studied
| All patients (N = 13) | Pt 1 | Pt 2 | Pt 3 | Pt 4 | Pt 5 | Pt 6 | Pt 7 | Pt 8 | Pt 9 | Pt 10 | Pt 11 | Pt 12 | Pt13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | 57.8 ± 10.0 | 64 | 55 | 57 | 68 | 73 | 53 | 46 | 65 | 63 | 57 | 34 | 57 | 59 |
| Sex, M | 12 (92.3%) | M | M | M | M | F | M | M | M | M | M | M | M | M |
| BMI, kg/m2 | 30.5 ± 5.6 | 22.6 | 26.6 | 31.5 | 25.2 | 28.1 | 40.6 | 38.6 | 31.7 | 35.3 | 26.1 | 24.8 | 30.7 | 34.8 |
| Comorbidities | ||||||||||||||
| Hypertension | 3 (23.1%) | N | N | N | N | N | N | N | Y | Y | N | N | Y | N |
| Heart failure | – | N | N | N | N | N | N | N | N | N | N | N | N | N |
| Coronary artery disease | 1 (7.7%) | N | N | N | N | N | N | N | Y | N | N | N | N | N |
| COPD | – | N | N | N | N | N | N | N | N | N | N | N | N | N |
| Asthma | 1 (7.7%) | N | Y | N | N | N | N | N | N | N | N | N | N | N |
| Diabetes | 1 (7.7%) | N | N | N | N | N | Y | N | N | N | N | N | N | N |
| Atrial fibrillation | 1 (7.7%) | N | N | N | Y | N | N | N | N | N | N | N | N | N |
| Dementia | 1 (7.7%) | N | N | N | Y | N | N | N | N | N | N | N | N | N |
| Stroke | 1 (7.7%) | N | N | N | Y | N | N | N | N | N | N | N | N | N |
| CKD | – | N | N | N | N | N | N | N | N | N | N | N | N | N |
| Blood gas analysis | ||||||||||||||
| PaO2, mmHg | 68.8 ± 7.1 | 67.2 | 76.8 | 80.1 | 67.0 | 62.8 | 76.0 | 66.0 | 73.0 | 60.0 | 68.5 | 74.1 | 68.7 | 57.2 |
| PaCO2, mmHg | 35.5 ± 3.6 | 34.6 | 39.9 | 35.3 | 37.0 | 35.4 | 28.0 | 37.0 | 31.0 | 34.6 | 40.7 | 39.2 | 37.0 | 31.9 |
| SaO2, % | 95.9 ± 1.7 | 95.0 | 96.7 | 97.5 | 99.0 | 94.0 | 98.0 | 95.0 | 96.0 | 93.0 | 95.6 | 96.3 | 95.0 | 94.2 |
| HCO3, mmol/l | 24.5 ± 1.5 | 24.3 | 25.5 | 22.9 | 26.1 | 22.0 | 24.5 | 24.7 | 22.6 | 26.0 | 26.9 | 25.3 | 24.1 | 23.8 |
| pH | 7.4 ± 0.0 | 7.46 | 7.42 | 7.43 | 7.46 | 7.42 | 7.51 | 7.44 | 7.45 | 7.49 | 7.43 | 7.42 | 7.43 | 7.46 |
| Functional status | ||||||||||||||
| 2-min walked distance, m | 134.4 ± 61.6 | 82 | 140 | 140 | 70 | 100 | 133 | 154 | 84 | 168 | 80 | 294 | 168 | n.a |
| Borg scale dyspnea | 2.5 ± 1.8 | 1 | 3 | 1 | 4 | 2 | 2 | 6 | 4 | 4 | 0 | 0 | 3 | n.a |
| Borg scale fatigue | 1.5 ± 1.7 | 1 | 3 | 0 | 0 | 0 | 2 | 5 | 0 | 3 | 1 | 0 | 3 | n.a |
| Nocturne SaO2, % | 91.2 ± 1.8 | 92.5 | 93.5 | 90.7 | 91.0 | 90.8 | 92.0 | 87.0 | 91.3 | 89.5 | 90.3 | 94.1 | 90.9 | 91.4 |
Data are means ± SD or number (percentage)
COPD chronic obstructive pulmonary disease, CKD chronic kidney disease, n.a. not able to perform